Introducing Xevo TQD from Waters - Robust. Rapid. Reliable.
Created to reduce complexity, the new Xevo TQD has been designed to deliver maximum productivity with minimum effort.
Created to reduce complexity, the new Xevo TQD has been designed to deliver maximum productivity with minimum effort.
For ultimate consistency between analyses; instrument to instrument, lab to lab; both the advanced technology of the ACQUITY UPLC System and the robust universal ion source architecture available with the Xevo TQD ensure dependability, while providing a flexible platform to accommodate ever changing sample types.
Xevo TQD is the only integrated system in its class that enables simultaneous acquisition of high quality quantitative and qualitative data from the widest range of experiments.
Xevo TQD – A cost effective solution that everyone in the lab can use.
FDA Approves Novartis Oral Treatment for Adults with C3 Glomerulopathy
March 25th 2025Fabhalta (iptacopan) received a positive opinion for treatment of C3G from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) and has been approved twice before by FDA.
